Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research
  • Published:

Initial validation of a novel rat model of vasculogenic erectile dysfunction with generalized atherosclerosis

Abstract

Although rats have been widely used in evaluating various causes of vasculogenic erectile dysfunction (VED), the atherosclerotic rat model has seldom been tried probably due to its inherent tolerance to a cholesterol diet. To enhance endothelial sensitivity to cholesterol diet, we tested the effects of transient interruption of nitric oxide synthase on atherogenesis induced by cholesterol diet in a rat model. Rats with atherosclerosis (AS group) received 1% cholesterol diet for 6 weeks. During the initial 2 weeks, they drank water that contained NG-nitro-L-arginine methyl ester (L-NAME) (3 mg/ml). After 6 weeks, we carried out histologic and hemodynamic evaluation to confirm pelvic atherosclerosis and erectile dysfunction, respectively, and the results were compared with those of cholesterol only (Chol) group and normal control (C) group. Compared to the C or Chol group, the mean intima/media (I/M) of the internal pudendal artery, which contributes approximately 70% of the total resistance of the penile vasculature, was markedly increased by the treatment (1.82±0.25 vs 0.77±0.13, P<0.05). Correspondingly, significantly diminished erectile function was observed. Combined treatment for 2 weeks elicited early atherosclerotic changes in proximal arteries and erectile impairment and further 4 weeks of cholesterol diet spread overt atherosclerosis to the periphery. The Chol group showed no arterial pathology, although they showed mild VED. A correlation study showed that atherosclerosis of the distal artery was better correlated with erectile dysfunction than the proximal artery. Based on these results, our study demonstrates that combination treatment of cholesterol diet with L-NAME would be used as a rapid, effective protocol of developing atherosclerotic rat model of VED.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 2
Figure 1
Figure 3

Similar content being viewed by others

References

  1. Michal V . Arterial disease as a cause of impotence. Clin Endocrinol Metab 1982; 11: 725–748.

    Article  CAS  Google Scholar 

  2. Udelson D et al. Engineering analysis of penile hemodynamic and structural–dynamic relationships: Part I—clinical implications of penile tissue mechanical properties. Int J Impot Res 1998; 10: 15–24.

    Article  CAS  Google Scholar 

  3. Udelson D et al. Engineering analysis of penile hemodynamic and structural–dynamic relationships: Part II—clinical implications of penile buckling. Int J Impot Res 1998; 10: 25–35.

    Article  CAS  Google Scholar 

  4. Udelson D et al. Engineering analysis of penile hemodynamic and structural–dynamic relationships: Part III—clinical considerations of penile hemodynamic and rigidity erectile responses. Int J Impot Res 1998; 10: 89–99.

    Article  CAS  Google Scholar 

  5. Siroky MB, Azadzoi KM . Vasculogenic erectile dysfunction: newer therapeutic strategies. J Urol 2003; 170: S24–S29.

    Article  Google Scholar 

  6. Kim JH et al. Experimental hypercholesterolemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth muscle cell dysfunction. J Urol 1994; 151: 198–205.

    Article  CAS  Google Scholar 

  7. Angulo J et al. Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF. Biochem Biophys Res Commun 2003; 312: 1202–1208.

    Article  CAS  Google Scholar 

  8. El-Sakka A, Yen TS, Lin CS, Lue TF . Traumatic arteriogenic erectile dysfunction: a rat model. Int J Impot Res 2001; 13: 162–171.

    Article  CAS  Google Scholar 

  9. Azadzoi KM, Goldstein I . Erectile dysfunction due to atherosclerotic vascular disease: the development of an animal model. J Urol 1992; 147: 1675–1681.

    Article  CAS  Google Scholar 

  10. Behr-Roussel D et al. Distinct mechanisms implicated in atherosclerosis-induced erectile dysfunction in rabbits. Atherosclerosis 2002; 162: 355–362.

    Article  CAS  Google Scholar 

  11. Gholami SS et al. The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia. J Urol 2003; 169: 1577–1581.

    Article  CAS  Google Scholar 

  12. Bakircioglu ME et al. Effect of a Chinese herbal medicine mixture on a rat model of hypercholesterolemic erectile dysfunction. J Urol 2000; 164: 1798–1801.

    Article  CAS  Google Scholar 

  13. Ritskes-Hoitinga J, Beynen AC . Atherosclerosis in the rat. Artery 1988; 16: 25–50.

    CAS  PubMed  Google Scholar 

  14. Kataoka C et al. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats. Hypertension 2002; 39: 245–250.

    Article  CAS  Google Scholar 

  15. Paick JS, Lee SW . The neural mechanism of apomorphine-induced erection: an experimental study by comparison with electrostimulation-induced erection in the rat model. J Urol 1994; 152: 2125–2128.

    Article  CAS  Google Scholar 

  16. Numaguchi K et al. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension 1995; 26: 957–962.

    Article  CAS  Google Scholar 

  17. Kitamoto S et al. Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II. J Hypertens 2000; 18: 1795–1800.

    Article  CAS  Google Scholar 

  18. Conner EM et al. Duration of the hemodynamic effects of N(G)-nitro-L-arginine methyl ester in vivo. Nitric Oxide 2000; 4: 85–93.

    Article  CAS  Google Scholar 

  19. Ferraz MR, Ferraz MM, Santos R, de Moura RS . Preventing L-NAME inhibitory effects on rat sexual behavior with hydralazine, isradipine or captopril co-treatment. Pharmacol Biochem Behav 2003; 75: 265–272.

    Article  CAS  Google Scholar 

  20. Kloner RA et al. Erectile dysfunction in the cardiac patient: how common and should we treat? J Urol 2003; 170: S46–S50.

    Article  Google Scholar 

  21. Albrecht EW et al. Protective role of endothelial nitric oxide synthase. J Pathol 2003; 199: 8–17.

    Article  Google Scholar 

  22. Behr-Roussel D et al. Erectile dysfunction in spontaneously hypertensive rats: pathophysiological mechanisms. Am J Physiol Regul Integr Comp Physiol 2003; 284: R682–R868.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J-S Paick.

Additional information

Supported by grant no. 03-2003-004-0 from the SNUH Research Fund

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, K., Son, H., Kim, S. et al. Initial validation of a novel rat model of vasculogenic erectile dysfunction with generalized atherosclerosis. Int J Impot Res 17, 424–430 (2005). https://doi.org/10.1038/sj.ijir.3901339

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901339

Keywords

This article is cited by

Search

Quick links